Fundraising Fox
Nexturebio
Founded 2023 · 8 employees on LinkedIn · 1 known investors
Find your way into Nexturebio
Sign up to see every warm intro you have to Nexturebio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nexturebio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nexture Bio develops the Doselet, a plant-based dissolvable nanofiber patch for oral nutraceutical delivery, applied to the inner cheek. Its first product delivers 10mg of NAD+ as an alternative to pills or injections for consumer wellness.
Founders & leadership
TM
Teryn Marie WolfeShe previously led Matrix Food Technologies, where she rose from director of corporate development and strategic relationships to vice president and then chief executive officer between 2021 and 2023. Earlier, she founded the Colombia-based consultancy Measurement Matters, served as executive director of The E2E Foundation, and taught at Universidad EAFIT and Universidad Nacional de Colombia in Medellín.
Investors · 1
Big Idea Ventureslisted by Big Idea VenturesMiami · $200K – $3.5M
How we know: Big Idea Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Nexturebio do?
- Nexture Bio develops the Doselet, a plant-based dissolvable nanofiber patch for oral nutraceutical delivery, applied to the inner cheek. Its first product delivers 10mg of NAD+ as an alternative to pills or injections for consumer wellness.
- Who are Nexturebio's investors?
- Nexturebio's investors include Big Idea Ventures.